{"status":"OK","data":{"id":2723715,"identifier":"DVN/AW0VXC","persistentUrl":"https://doi.org/10.7910/DVN/AW0VXC","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2016-03-10","storageIdentifier":"s3://dvn-cloud:10.7910/DVN/AW0VXC","latestVersion":{"id":77857,"storageIdentifier":"s3://dvn-cloud:10.7910/DVN/AW0VXC","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","lastUpdateTime":"2016-03-10T09:15:41Z","releaseTime":"2016-03-10T09:15:41Z","createTime":"2015-11-10T03:05:01Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Labcode 5A- HIV neutralization testing with PBMC"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Lindsay Wieczorek"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"Henry Jackson Foundation, USA"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Lindsay Wieczorek"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"Henry Jackson Foundation, USA"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"lwieczorek@hivresearch.org"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"This protocol describes a HIV neutralisation assay in the microtiter plate format, that measures reduction in virus infectious titer mediated by exposure to polyclonal or monoclonal reagents.  Virus infection in donor PHA-stimulated peripheral blood mononuclear cells (PBMC) is assessed by quantitative ELISA of HIV-1 p24 antigen in PBMC culture supernatants."}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences"]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"sheik-khalil, enas"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2015-11-09"}]}},"files":[{"description":"","label":"Labcode 5A- HIV neutralization testing with PBMC.pdf","restricted":false,"version":1,"datasetVersionId":77857,"dataFile":{"id":2723716,"persistentId":"doi:10.7910/DVN/AW0VXC/LKU1AN","pidURL":"https://doi.org/10.7910/DVN/AW0VXC/LKU1AN","filename":"Labcode 5A- HIV neutralization testing with PBMC.pdf","contentType":"application/pdf","filesize":221239,"description":"","storageIdentifier":"s3://dvn-cloud:150ef5a7504-44b124dde53a","rootDataFileId":-1,"md5":"baa3d9da40b469ea2c38f36c6dffb830","checksum":{"type":"MD5","value":"baa3d9da40b469ea2c38f36c6dffb830"}}}]}}}